Bidvest-subsidiary Adcock Ingram says profits improved in the year to end-June, thanks in part to better sales of prescription medication.

That helped boost the company’s shares as much as 5.4% to R58.48 on Wednesday morning.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now